Paper630199
Prednimustine therapy for advanced prostatic cancer.
Catane R and 4 others. Br J Urol, 1978. Cited by 26 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Prednimustine therapy for advanced prostatic cancer. Papers, record 630199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/630199
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chlorambucil | Major topic |
| Prednisolone | Major topic |
| Prostatic Neoplasms | Major topic |
| Adrenal Glands | |
| Aged | |
| Chemical Phenomena | |
| Chemistry | |
| Drug Combinations | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15,570,307 | Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding. | Br J Cancer | 2005 | https://conductscience.org/library/papers/15570307 | PubMed |
| 7,679,331 | Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/7679331 | PubMed |
| 6,871,484 | Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study. | Breast Cancer Res Treat | 1983 | https://conductscience.org/library/papers/6871484 | PubMed |
| 6,640,823 | Disposition of orally administered 14C-prednimustine in cancer patients. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6640823 | PubMed |
| 6,254,684 | Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6254684 | PubMed |
| 1,537,076 | Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1537076 | PubMed |
| 394,873 | Prednimustine in adult acute myeloid leukaemia. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/394873 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/630199
GET https://conductscience.org/api/papers/v1/630199/authors